Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Current Assets (2023 - 2026)

Updated

Genmab A's Current Assets was $2.8 billion in the quarter ended Jun 30, 2026, up 8.9% from the prior quarter.

Analysis

Genmab A (GMAB) Current Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Current Assets at Genmab A came in at $2.89 billion, down 26.0% from the prior year.

  • In earlier years, Current Assets was $3.9 billion in the year ended Dec 31, 2024 (-20.6%) and $4.91 billion in the year ended Dec 31, 2023.
  • Quarterly Current Assets has moved between $691.93 million (the quarter ended Sep 30, 2025) and $4.91 billion (the quarter ended Dec 31, 2023) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 56.35 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 37.48 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 27.97 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 16.55 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 45.01 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn 2.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.19 Bn
Jun 30, 2026 2.80 Bn
Mar 31, 2026 2.57 Bn
Dec 31, 2025 2.89 Bn
Sep 30, 2025 691.93 Mn
Jun 30, 2025 3.91 Bn
Mar 31, 2025 4.04 Bn
Dec 31, 2024 3.90 Bn
Dec 31, 2023 4.91 Bn
Jan 1, 2023 4.05 Bn
API Access

Genmab A Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY